Clinical Trails of Photoelectrochemical Immunosensor for Early Diagnosis of Acute Myocardial Infarction
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Effectiveness of photoelectrochemical immunosensor
Study Overview
Brief Summary
The aim of this prospective randomized controlled clinical trial will evaluate the sensitivity, precision and effectiveness of photoelectrochemical immunosensor for early diagosis of acute myocardial infarction.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Diagnostic
- Masking
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Eligibility Criteria
- Ages
- 18 Years to 100 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Age > 18 years
- •Symptoms of chest pain
Exclusion Criteria
- •Patients who will undergo immediate PCI Pregnant
- •Lactating women
- •Patients with mental disorders
- •Patients are using other experimental drugs; Refusal to provide informed.
Arms & Interventions
control
Automatic chemiluminescence analyzer will be used for dectecting the concentration of cardiac troponin I as control group.
Photoelectrochemical immunosensor
Photoelectrochemical immunosensor will be used for dectecting the concentration of cardiac troponin I as test group.
Intervention: Graphene quantum dots combined with Si nanowire photoelectrochemical immunosensor (Device)
Outcomes
Primary Outcomes
Effectiveness of photoelectrochemical immunosensor
Time Frame: 28 days
Sensitivity，precision and cost of the photoeletrochemical immunosensor
Secondary Outcomes
No secondary outcomes reported
Investigators
Bin He
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine